• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿洛西林和羧苄西林对856株临床分离菌的体外活性比较。

Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.

作者信息

Skar A G, Midtvedt T, Dahl O

出版信息

NIPH Ann. 1984 Jun;7(1):13-9.

PMID:6493580
Abstract

Eight hundred and fifty-six strains of more than ten species: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus faecalis, Escherichia coli, Klebsiella spp, Proteus mirabilis, Proteus vulgaris, Enterobacter spp, Pseudomonas spp and Acinetobacter spp, were tested by the disc diffusion method against azlocillin and carbenicillin. Azlocillin was found to be superior to carbenicillin against Pseudomonas spp, and more than 90% of the tested strains had minimal inhibitory concentration (MIC) values well below the serum levels attainable after recommended doses of azlocillin. Against Enterobacteriaceae and Gram-positive cocci, however, azlocillin seemed to have little to offer.

摘要

采用纸片扩散法,对金黄色葡萄球菌、表皮葡萄球菌、粪肠球菌、大肠杆菌、克雷伯菌属、奇异变形杆菌、普通变形杆菌、肠杆菌属、假单胞菌属和不动杆菌属等十多个菌种的856株菌株进行了针对阿洛西林和羧苄西林的测试。结果发现,阿洛西林对假单胞菌属的抗菌效果优于羧苄西林,超过90%的受试菌株的最低抑菌浓度(MIC)值远低于推荐剂量阿洛西林给药后所能达到的血清水平。然而,对于肠杆菌科细菌和革兰氏阳性球菌,阿洛西林似乎并无明显优势。

相似文献

1
Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.阿洛西林和羧苄西林对856株临床分离菌的体外活性比较。
NIPH Ann. 1984 Jun;7(1):13-9.
2
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.替卡西林:与羧苄西林针对9000多株临床分离细菌的体外协同比较
Am J Med Sci. 1977 Nov-Dec;274(3):255-63.
3
A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.一种新型头孢菌素头孢呋辛与头孢噻吩对810株临床分离菌的体外活性比较。
NIPH Ann. 1979 Dec;2(2):31-40.
4
[Antibacterial spectrum of mezlocillin and MIC/disc correlations (author's transl)].
Nouv Presse Med. 1982 Feb 4;11(5 Pt 2):309-13.
5
Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.对来自小火鸡的1570株细菌分离株进行多种抗菌剂的最低抑菌浓度测定。
Avian Dis. 2000 Jan-Mar;44(1):85-98.
6
Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.通过多种体外方法评估环丙沙星与其他药物的协同作用。
Am J Med. 1987 Apr 27;82(4A):44-54.
7
Azlocillin: in vitro studies of a new semisynthetic penicillin.阿洛西林:一种新型半合成青霉素的体外研究
Antimicrob Agents Chemother. 1977 May;11(5):865-70. doi: 10.1128/AAC.11.5.865.
8
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.环丙沙星与阿洛西林在体外及中性粒细胞减少小鼠感染模型中的协同作用。
Eur J Clin Microbiol. 1986 Feb;5(1):23-8. doi: 10.1007/BF02013456.
9
[Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].阿帕西林:与羧苄西林、替卡西林、美洛西林、哌拉西林相比,对肠杆菌科细菌和不动杆菌的体外活性
Pathol Biol (Paris). 1983 Jun;31(6):463-6.
10
[In vitro antibacterial activity of cefmenoxime (SCE 1365)].
Pathol Biol (Paris). 1983 May;31(5):343-6.